INTEGRATED BIOPHARMA INC is a pharmaceuticals company based out of 225 Long Avenue, Hillside, New Jersey, United States.

Information Technology & Services

Synray Corp is an accounting company based out of 209 N Michigan Ave, Kenilworth, New Jersey, United States.

Glitter manufacturer and glitter precision cutting.

Flexabar Corporation is a marketing and advertising company based out of 1969 Rutgers University B, Lakewood, New Jersey, United States.

Enalare Therapeutics Inc. is a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.

LAC is a fourth-generation family owned business specializing in the global importing and exporting of essential oils (byproducts, resinoids/gums and concretes/absolutes) and aromatic chemicals for the flavor and fragrance industry. We are able to offer organics, Kosher and Halal certified products. With over 80 years of combined experience we provide excellent customers service, pricing and product portfolio along with in-depth market insight. We pride ourselves on bringing reliable, sustainable and superior products to the table. We always maintain 100% transparency and traceability.With strategically placed locations internationally L. A. Champon can provide logistics , warehousing & import services in the USA and EU. Please contact us for any of your needs.

Bionex’s mission is to realize the applications of bio-pharmaceutical and life sciences into commercial products and services that benefit human health. Strategically, Bionex engages in two areas of business activities. First, Bionex offers contract R&D services, from early-stage concept development, cGMP clinical supply manufacturing to full-scale commercialization, for bio-pharmaceutical products. Second, Bionex develops and out-licenses its own proprietary formulations, drug delivery technologies, and products related to medical, health food, and skin-care applications. Our expertise is focused on transdermal and transmucosal drug systems. We adopt a science-based, and yet pragmatic and out-of-box approach which often leads to fruitful outcomes, in time- and cost-effective manner. Bionex capabilities are its expertise in formulation science and analytical chemistry, full range of formulation/processing, analytical, and testing capabilities in cGMP facility, and well-connected network of industrial, academic and business consultants and advisors. Many of our in-house innovation R&D projects are funded by National Institute of Health (NIH), National Science Foundation (NSF), state grants and non-for-profit organizations.

Longevity Biotech is developing new therapeutic drug candidates, which may have direct clinical impacts on patients lives. All of our programs are based on our Hybridtide peptide scaffold technology. Hybridtides are designed for long-acting oral administration.